PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93025C00038Development of pan-influenza inhibitors — Cocrystal Pharma, Inc

Cocrystal Pharma, Inc holds $498K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 4 offers. Set-aside status: Small business. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid
Awarding office
Cocrystal Pharma, Inc
Recipient
Sep 29, 2026
PoP end
$498K
Obligated
$498K
Potential
541714
NAICS
AN12
PSC
Small business
Set-aside
4 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Small business
Contract number75N93025C00038
AgencyNational Institutes Of Health Niaid
Awarding officeNational Institutes Of Health Niaid
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentCocrystal Pharma, Inc
CAGE7SGF5
UEIUY8UDESGRJ17
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12
Place of performanceBOTHELL WA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition After Exclusion Of Sources
Related solicitationPHS 2025-1
PoP startSep 29, 2025
PoP end (current)Sep 29, 2026
Obligated$498K
Current value$498K
Potential value$498K

DEVELOPMENT OF PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX is a federal Small business award for National Institutes Of Health Niaid held by Cocrystal Pharma, Inc. Estimated value $498K ($498K obligated). Current period of performance ends Sep 29, 2026. Last award drew 4 bidders. Place of performance: BOTHELL WA. Related solicitation PHS 2025-1.

DEVELOPMENT OF PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX

Recompete timing

Public
● Expiring in 2 days

Current PoP ends Sep 29, 2026 (2 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75N93025C00038? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Cocrystal Pharma, Inc — $498K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$498K · 100% of firm total
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N93025C00038?

75N93025C00038 (Development of pan-influenza inhibitors) is a National Institutes Of Health Niaid award with a potential value of $498K, currently held by Cocrystal Pharma, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93025C00038?

National Institutes Of Health Niaid awarded 75N93025C00038 to Cocrystal Pharma, Inc (potential $498K).

Who is the incumbent on 75N93025C00038?

Cocrystal Pharma, Inc is the incumbent with $498K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does Cocrystal Pharma, Inc’s 75N93025C00038 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N93025C00038? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N93025C00038